Evaluation of a nonopioid recovery pathway after percutaneous nephrolithotomy

Pilot Project Awardee
12/1/2020 – Present

David W. Sobel, MD

David W. Sobel, MD

Clinical Fellow, Minimally Invasive Urologic Surgery, Board Eligible Urologic Surgeon; Clinical Instructor, Department of Surgery, Division of Urology

The Miriam Hospital, Department of Surgery, Division of Urology

Tel: 401-421-0710
Email: Dsobel1@lifespan.org

Evaluation of a nonopioid recovery pathway after percutaneous nephrolithotomy is a pragmatic pilot study that will apply the knowledge and experience gained with development of an outpatient opioid reduction protocol to percutaneous nephrolithotomy (PCNL). We have previously demonstrated that outpatient ureteroscopy and stent placement without postoperative opioid prescriptions is possible in the vast majority of patients. The success of this is dependent upon a multimodal approach to the patient’s experience of undergoing endoscopic kidney stone surgery (ureteroscopy) and focuses on the preoperative, perioperative, and postoperative stages of intervention. Our hypothesis is that a novel nonopioid pathway after PCNL is both feasible and safe and will reduce postoperative prescriptions for opioids without impacting clinical outcomes, patient satisfaction or outpatient resources.